Copyright
        ©The Author(s) 2023.
    
    
        World J Biol Chem. Mar 27, 2023; 14(2): 52-61
Published online Mar 27, 2023. doi: 10.4331/wjbc.v14.i2.52
Published online Mar 27, 2023. doi: 10.4331/wjbc.v14.i2.52
            Table 1 Demographic table
        
    | Features  | Median [Q1-Q3] or frequency [%] | 
| Age (yr) | 50.00 [36.00-61.00] | 
| Gender | |
| Male | 326 [66.0] | 
| Female | 168 [34.0] | 
| IgG (AU/mL) | 7.82 [0.63-57.07] | 
| IgG | |
| < 10 AU/mL | 231[50.99] | 
| > 10 AU/mL | 224 [49.01] | 
| IgM (AU/mL) | 0.96 [0.48-7.68] | 
| IgM | |
| < 10 AU/mL | 352 [77.37] | 
| > 10 AU/mL | 103 [22.8] | 
| RT-PCR | |
| Positive | 199 [40.4] | 
| Negative | 294 [59.6] | 
| Onset-Testing Interval (d) | 12.00 [7.00-21.00] | 
- Citation: Suresh M, Kumar P, Panda PK, Jain V, Raina R, Saha S, Vivekanandhan S, Omar BJ. Correlation of serum SARS-CoV-2 IgM and IgG serology and clinical outcomes in COVID-19 patients: Experience from a tertiary care centre. World J Biol Chem 2023; 14(2): 52-61
 - URL: https://www.wjgnet.com/1949-8454/full/v14/i2/52.htm
 - DOI: https://dx.doi.org/10.4331/wjbc.v14.i2.52
 
